Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases
- PMID: 20200515
- PMCID: PMC4120751
- DOI: 10.1038/clpt.2010.2
Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases
Abstract
Members of the nuclear receptor (NR) superfamily of ligand-activated transcription factors are players of substantial relevance in the regulation of hepatic gene expression. NRs direct normal physiology and metabolism, adaptations to liver disease, and responses to inflammation and toxins.They also contribute to the regenerative response. In this review, we summarize currently available experimental and clinical data, focusing on the role of NRs in cholestasis and nonalcoholic fatty liver disease (NAFLD). We also highlight the potential of NRs as targets for safe and effective therapeutic interventions.
References
-
- Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–35. - PubMed
-
- Dasarathy S. Inflammation and liver. JPEN J Parenter Enteral Nutr. 2008;32:660–6. - PubMed
-
- Ramadori G, Moriconi F, Malik I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol. 2008;59 (Suppl 1):107–17. - PubMed
-
- Iredale J. Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair. Pharmacol Res. 2008;58:129–36. - PubMed
-
- Downes M, Liddle C. Look Who’s Talking: Nuclear Receptors in the Liver and Gastrointestinal Tract. Cell Metabolism. 2008;7:195–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources